SCHEMBL570573

SCHEMBL570573

O=C(O)N1CCC(C(O)c2ccccc2-c2ccc(Cl)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
BCL2 P10415 3/20 0.38
BCL2L1 Q07817 3/20 0.38
HSD11B1 P28845 4/20 0.38
MAPT P10636 2/20 0.37
CCR1 P32246 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
IDO1 P14902 1/20 0.37
OPRD1 P41143 1/20 0.36
FFAR2 O15552 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL570865 0.83 MGLL (0.42) MGLLMEN1KMT2ABCL2BCL2L1
SCHEMBL553728 0.83 MEN1 (0.50) MEN1KMT2AIDO1
SCHEMBL553729 0.83 MEN1 (0.50) MEN1KMT2AIDO1
SCHEMBL554530 0.83 MEN1 (0.50) MEN1KMT2AIDO1
SCHEMBL31450899 0.83 MEN1 (0.50) MEN1KMT2AIDO1
SCHEMBL554396 0.82 BCL2L1 (0.46) BCL2BCL2L1LMNA
SCHEMBL31450836 0.82 BCL2L1 (0.46) BCL2BCL2L1LMNA
SCHEMBL31451040 0.82 BCL2L1 (0.46) BCL2BCL2L1LMNA
SCHEMBL553748 0.82 BCL2L1 (0.46) BCL2BCL2L1LMNA
SCHEMBL553747 0.82 BCL2L1 (0.46) BCL2BCL2L1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601177-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS AstraZeneca AB (SE) 2013-06-12 EP disclosed
WO-2012017251-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ASTRAZENECA AB (SE) 2012-02-09 WO disclosed